Visualitza per autor "Goker, Erdem"
Ara mostrant els elements 1-1 d 1
-
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial
Goss, Glenwood D.; Syrigos, Konstantinos; Lee, Ki Hyeong; Goker, Erdem; Felip Font, Enriqueta; Cobo, Manuel; Lu, Shun (Elsevier, 2021-07)